Stay updated with breaking news from Caredx. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Analysts forecast that CareDx, Inc (NASDAQ:CDNA – Get Rating) will post earnings per share (EPS) of ($0.04) for the current quarter, Zacks reports. Three analysts have made estimates for CareDx’s earnings. CareDx posted earnings per share of $0.14 during the same quarter last year, which would indicate a negative year over year growth rate of […]
Represents World’s First Surveillance Solutions for Investigational Use in Xenotransplantation Research and Post-Xenotransplant Clinical Monitoring...
New Features Aim to Help More Patients with Kidney Failure Receive an Organ Transplant...
Jury Finds Natera Falsely Advertised its Prospera Kidney Transplant TechnologySOUTH SAN FRANCISCO, Calif., March 23, 2022 -- CareDx, Inc. , a leading precision medicine company focused on the... | March 23, 2022
SOUTH SAN FRANCISCO, Calif., March 16, 2022 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ focused on the discovery,...